docetaxel anhydrous has been researched along with talabostat in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (talabostat) | Trials (talabostat) | Recent Studies (post-2010) (talabostat) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 33 | 4 | 17 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | talabostat (IC50) |
|---|---|---|---|
| Kynurenine 3-monooxygenase | Rattus norvegicus (Norway rat) | 0.066 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.98 | |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | 0.1666 | |
| Prolyl endopeptidase | Homo sapiens (human) | 1.8476 | |
| Prolyl endopeptidase FAP | Mus musculus (house mouse) | 0.0673 | |
| Prolyl endopeptidase FAP | Homo sapiens (human) | 0.0792 | |
| Dipeptidyl peptidase 8 | Homo sapiens (human) | 0.0113 | |
| Dipeptidyl peptidase 9 | Homo sapiens (human) | 2.2681 | |
| Dipeptidyl peptidase 2 | Homo sapiens (human) | 0.0437 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cunningham, CC; Eager, RM; Jones, B; Nemunaitis, J; Raju, RN; Richards, DA; Senzer, N; Uprichard, M | 1 |
1 trial(s) available for docetaxel anhydrous and talabostat
| Article | Year |
|---|---|
Phase II trial of talabostat and docetaxel in advanced non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Carcinoma, Non-Small-Cell Lung; Dipeptides; Docetaxel; Humans; Lung Neoplasms; Middle Aged; Taxoids | 2009 |